The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity (New Diabetes Company).

In a surprise move, Medtronic plans to spin off its diabetes business. This is Medtronic's smallest business, but also its fastest-growing one. The new entity could be attractive to more growth ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit ...

Business Medtronic to spin off diabetes business, form new company The separation is expected to be completed in 18 months.

Medical-device maker Medtronic MDT -0.13% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

Medtronic said Wednesday it plans to separate its diabetes business, which generates more than $2.8 billion in annual sales, into a new publicly traded company.

The company says it plans to separate the two entities within 18 months but will still need to get the approval of the Medtronic Board of Directors.

Medtronic announces intent to separate Diabetes business Medtronic announces intent to separate Diabetes business PR Newswire GALWAY, Ireland, May 21, 2025 Enables intense focus on highest margin ...